Among the 6 actionable alterations, EML4-ALK (exon 20: exon 20) fusion, ERBB2 Y772_A755dupYVMA and KRAS G12C showed a consistency of 100% between PE-cfDNA and pericardial effusion. The gene discussed is EML4; the disease is pericardial effusion.